Navigation Links
New CSS program helps PartD sponsors meet CMS drug overutilization requirements
Date:6/20/2012

BUFFALO, N.Y., June 20, 2012 /PRNewswire/ -- Those working in Medicare programs have full schedules, filled with program submission rules, standardized formats, policy changes, data validation audits, on-site audits and more. Just when it seems there aren't enough hours in the day to get it all done, the Centers for Medicare & Medicaid Services (CMS) is adding even more oversight by getting tough on prescription overutilization by Medicare beneficiaries, and Clinical Support Services, Inc. (CSS) has a new program to help identify and track those most at risk.

CSS's new program helps Medicare plans offering prescription coverage to meet CMS's new requirements for retrospective drug utilization review by identifying "patterns which suggest that the identified patients may be at risk of overutilization. Part D sponsors should create and monitor Part D utilization reports to identify patterns of apparent duplicative drug use over sustained periods of time and/or across multiple drug products," according to the CY2013 Final Call Letter.

CSS's program reviews pharmacy claims and plan eligibility data monthly, then flags patients of concern by using predetermined selection criteria such as number of prescriptions filled in a 30-day period for frequently abused drug classes; number of physicians prescribing medication for that patient; and number of pharmacies filling prescriptions for that patient. Medicare plans receive a data report to determine the best course of action for that patient.

"Medicare plans have had even more responsibility thrust upon them," said James Notaro, RPh, Ph.D., CSS president. "This is a serious problem that needs serious consideration."

About CSS: Founded in 1999 by pharmacists and technologists, CSS is staffed by experienced clinicians, software developers and operations personnel who develop innovat
'/>"/>

SOURCE Clinical Support Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Accuray Rolls Out Comprehensive Customer Service Program in Japan
2. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
3. Effectiveness of Medicare Authorization Program for Power Wheelchairs Rests on Inclusion of a Clinical Template
4. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
5. Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
6. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
7. American Medical Systems and Allergan Sign Agreement for JetTouch™/BOTOX® Co-Development Program
8. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
9. Pennsylvania DEP Announces X-ray Registration Fee Amnesty Program
10. Liberty Dialysis Celebrates Milestone 1,000th Patient in Peritoneal Dialysis Program
11. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... LAKE, N.J. , May 30, 2015  Eisai Inc. ... 309), which showed that eribulin met the study,s primary endpoint ... or adipocytic sarcoma (ADI), two types of advanced soft tissue ... Annual Meeting of the American Society of Clinical Oncology ... the ASCO press conference on Saturday, May 30, and also ...
(Date:5/30/2015)... May 30, 2015 Caris Life Sciences®, ... promise of precision medicine, today announced the presentation ... utility of Caris Molecular Intelligence®, the company,s panomic ... tumors that share histological features. In separate presentations ... of Clinical Oncology (ASCO) in Chicago, ...
(Date:5/29/2015)... May 29, 2015 /CNW/ - Alliance Principle Ingredients/Neutrical Solutions ... the health product Galenic Health Ginger in Bentonite ... for adolescents and children. The product currently contains ... but within acceptable limits for adult dosing. ... digestive upset and disturbances. Alliance Principle Ingredients / ...
Breaking Medicine Technology:Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
(Date:5/30/2015)... 2015 Promising clinical trial results presented ... Meeting 2015 show activity of the investigational anti-cancer agent ... against brain metastases and in another case in overall ... "I am thrilled to have been able to offer ... She didn't have any other great treatment options that ...
(Date:5/30/2015)... 30, 2015 Thousands of aesthetic industry ... Meeting, sponsored by the American Society for Aesthetic Plastic ... hand was Zeltiq, the parent company of one of ... With blazing growth, the one-of-a-kind device just sold ... Zeltiq is currently in the news for gaining the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 NovaSure® endometrial ... lighten or stop periods, without the side effects ... can reduce or stop menstrual bleeding and works by ... (the part that causes the bleeding), with a quick ... suffer from heavy menstrual bleeding. Many women begin ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 The results ... crocidolite asbestos has a high potential to cause mesothelioma, ... full story now on the Surviving Mesothelioma website. ... of Occupational Medicine in Lodz, Poland found that, among ... workers between 1970 and 2012, all of them happened ...
(Date:5/30/2015)... 30, 2015 One of the pervasive ... local healthcare options available. Often, the ruralness of a ... those in rural areas feeling the crunch of a ... or tired of paying high premiums and copays, ... with licensed physicians via the power of the internet. ...
Breaking Medicine News(10 mins):Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3
... at the place of work, according to a recent study ... between stress and poor health has also been identified by ... metabolic syndrome and stress among the 10,000 civil servants belonging ... who were studied, which also involves high blood pressure and ...
... Indian population. This disease is due to the inability of the ... be due to the inability of the body to maintain normal ... slight modification in the lifestyle can help the patients to tackle ... Hospital for Diabetes Research Center, Royapuram and was headed by the ...
... at the Max Planck Institute for Developmental Biology in Tübingen (now ... able to identify a // protein that seems to play a ... ,The protein called Staufen2, appears to play a ... if this protein was blocked out from a nerve cell, it ...
... Iceland-based Ossur hf., a global orthopaedics company, has acquired ... $ 38.4 million. ,The acquisition of Innovation ... acquisition// of Royce Medical in the U.S., and the ... With these acquisitions, and its 2003 acquisition of Generation ...
... Comprehensive Cancer Center – Arthur G. James Cancer Hospital ... tumor suppressor gene that could be of vital significance ... well as lung cancer. //Their study shows that activating ... the aforementioned cancers. ,The gene, called TCF21 is ...
... available to Canadians from supermarkets and corner stores as a ... from making crystal meth. //The supermarkets and drug stores which ... which will come into force from 10 April 2006. Only ... are of the single ingredient category. This is inclusive of ...
Cached Medicine News:Health News:Protein Found to Be Essential For Maintaining Nerve Health 2Health News:Ossur Acquires the U.S. Orthopaedics Company 2Health News:Unusual Tumor-Suppressor Gene Switches Off in Lung Cancer 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
... The Vitek is a completely automated instrument ... of 2 - 6 hour same day ... quality control module. It is used for ... and urine screening and has a complete ...
IDS Rapid One, a microbial identification system....
Medicine Products: